Ken Bartizal

All filings by Ken Bartizal on record concern Trius Therapeutics Inc. Over a trading history stretching from 17 November 2011 to 11 September 2013, the count stands at 7 filings.

Sales make up the whole of the open-market record (6 sales, €254k). In 2013 alone, the filings show no purchases and 5 sales.

The newest entry dates from 13 September 2013: a transaction, in Trius Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.